Fig 1.
Clinical and laboratory characteristics between persons with and without hypertension.
Showing median (interquartile range, IQR) between persons with and without hypertension, respectively, followed by the overall median (IQR) for the population: A). Age, 38 (24–42) vs. 32 (24–42) years; 32 years, p = 0.03. B). BMI, 22 (20.00–24.00) vs. 21 (20.00–24.00) kg/m2; 21.00 kg/m2, p = 0.04. C). WBC, 7.49 (4.49–8.46) vs. 6.19 (4.49–8.46) x 103/Ul; 6.27 x 103/Ul, p = 0.29. D). ANC, 5.19 (3.43–7.21) vs. 3.41 (3.43–7.21) x 103/Ul; 3.64 x 103/Ul, p = 0.003. E). ALC, 1.82 (1.21–2.15) vs. 1.63 (1.21–2.15) x103/Ul; 1.65 x103/Ul, p = 0.39. F). AMC, 0.72 (0.48–1.00) vs. 0.53 (0.40–0.78) x103/Ul; 0.56 x103/Ul, p = 0.02. G). HbG,12.9 (11.20–14.50) vs. 13.1 (11.20–14.50) g/dl; 13.10 g/dl, p = 0.32. H). APC, 193.50 (158.00–251.00) vs. 202.00 (158.00–251.00) x103/Ul; 199.0 x103/Ul, p = 0.60. I). ABC, 0.01 (0.01–0.02) vs. 0.01 (0.01–0.02) x103/Ul; 0.01, p = 0.37. J). AEC, 0.04 (0.01–0.13) vs. 0.04 (0.01–0.15) x103/Ul; 0.04, p = 0.68. K). NLR, 3.20 (1.19–3.17) vs. 2.05 (1.19–3.17); 2.10, p = 0.06. L). LMR, 2.56 (2.04.-4.63) vs. 2.93 (2.04.-4.63); 2.88, p = 0.29. M). PLR, 111.48 (95.97–167.17) vs.122.81 (95.97–167.17); 120.63, p = 0.20. N). d-NLR, 2.38 (1.19–3.17) vs. 1.43 (1.19–3.17); 1.50, p = 0.03. WBC, white blood cell; AMC, absolute monocyte count; ALC, absolute lymphocyte; ANC, absolute neutrophil count; APC, absolute platelet count; HBG, hemoglobin; AEC, absolute eosinophil count; ABC, absolute basophil count; LMR, lymphocyte-monocyte ratio; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; d-NLR, derived neutrophil-lymphocyte ratio.
Table 1.
Comparison of sociodemographic and clinical factors between normotensive and hypertensive in the whole population.
Fig 2.
Comparison of demographic and CBCIS between people with and without HIV.
Showing median (interquartile range, IQR) between persons without and with HIV, respectively: A). Age, 31 (23–39) vs. 36 (27–48) years, p = 0.001. B). BMI, 21 (20–23) vs. 21 (20–23) kg/m2, p = 0.83. C). WBC, 6.36 (4.60–8.73) vs. 6.07 (4.49–8.97) x 103/Ul, p = 0.64. D). ANC, 3.74 (2.43–5.92) vs. 3.38 (2.09–5.92) x 103/Ul, p = 0.23. E). ALC, 1.59 (1.15–2.13) vs. 1.73 (1.29–2.25) x103/Ul, p = 0.15. F). AMC, 0.60 (0.43–0.86) vs. 0.50 (0.37–0.74) x103/Ul, p = 0.01. G). HbG,13.10 (11.10–14.40) vs. 13.20 (11.25–14.70) g/dl, p = 0.46. H). APC, 199 (151–255) vs. 199 (161–264) x103/Ul, p = 0.43. I). ABC, 0.01 (0.01–0.02) vs. 0.01 (0.01–0.02) x103/Ul, p = 0.37. J). AEC, 0.03 (0.01–0.12) vs. 0.05 (0.02–0.17) x103/Ul, p = 0.004. K). NLR, 2.48 (1.37–4.54) vs. 1.88 (1.01–3.82), p = 0.05. L). LMR, 2.56 (1.66–3.96) vs. 3.31 (2.08–5.17), p<0.001 M). PLR, 123 (95–168) vs.115 (96–159), p = 0.31. N). d-NLR, 1.60 (0.94–2.96) vs. 1.35 (0.84–2.56), p = 0.22. WBC, white blood cell; AMC, absolute monocyte count; ALC, absolute lymphocyte; ANC, absolute neutrophil count; APC, absolute platelet count; HBG, hemoglobin; AEC, absolute eosinophil count; ABC, absolute basophil count; LMR, lymphocyte-monocyte ratio; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; d-NLR, derived neutrophil-lymphocyte ratio.
Table 2.
Comparison of sociodemographic and clinical factors between normotensive and hypertensive in both people living with and without HIV.
Table 3.
Factors associated with hypertension in the whole population logistic regression.
Table 4.
Factors associated with hypertension in people with and without HIV.
Fig 3.
ROC curve for predictors of hypertension in the whole population.
Use of the receiver operating characteristic curve to see which CBCIS score best predicts hypertension in the whole population. The area under the curve (95%CI, p = value) for WBC = 0.55 (0.44–0.66, p = 0.30), ALC = 0.53 (95%CI 0.44–0.62, p = 0.45), AMC = 0.61 (95%CI 0.50–0.71, p = 0.029), ANC = 0.65 (95%CI 0.56–0.73, p = 0.004), APC = 0.47 (95%CI 0.38–0.57, p = 0.67), NLR = 0.59 (95%CI 0.51–0.68, p = 0.05), PLR = 0.44 (95%CI 0.35–0.53, p = 0.26), d-NLR = 0.61 (95%CI 0.50–0.71, p = 0.032) and LMR = 0.43 (95%CI 0.34–0.52). WBC, white blood cell; AMC, absolute monocyte count; ALC, absolute lymphocyte; ANC, absolute neutrophil count; APC, absolute platelet count; HBG, hemoglobin; LMR, lymphocyte-monocyte ratio; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; d-NLR, derived neutrophil-lymphocyte ratio.
Fig 4.
ROC curve for predictors of hypertension in persons with and without HIV.
A) Persons without HIV. B). Persons with HIV. WBC, white blood cell; AMC, absolute monocyte count; ALC, absolute lymphocyte; ANC, absolute neutrophil count; APC, absolute platelet count; HBG, hemoglobin; LMR, lymphocyte-monocyte ratio; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; d-NLR, derived neutrophil-lymphocyte ratio.
Table 5.
Area under the curve in persons living without and with HIV.